Steven Valiquette
Stock Analyst at Mizuho
(3.29)
# 1,034
Out of 5,093 analysts
121
Total ratings
51.56%
Success rate
2.64%
Average return
Main Sectors:
Stocks Rated by Steven Valiquette
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PHR Phreesia | Maintains: Outperform | $36 → $28 | $15.75 | +77.78% | 2 | Dec 10, 2025 | |
| LFMD LifeMD | Maintains: Neutral | $8 → $6 | $3.58 | +67.60% | 2 | Nov 19, 2025 | |
| GDRX GoodRx Holdings | Maintains: Neutral | $5 → $4 | $2.69 | +48.70% | 1 | Nov 6, 2025 | |
| COR Cencora | Maintains: Outperform | $340 → $380 | $339.24 | +12.02% | 3 | Nov 6, 2025 | |
| CAH Cardinal Health | Maintains: Outperform | $170 → $210 | $198.66 | +5.71% | 7 | Nov 4, 2025 | |
| WAY Waystar Holding | Maintains: Outperform | $48 → $50 | $29.90 | +67.22% | 2 | Oct 30, 2025 | |
| ALGN Align Technology | Maintains: Outperform | $210 → $170 | $161.23 | +5.44% | 12 | Oct 13, 2025 | |
| MCK McKesson | Maintains: Neutral | $750 → $770 | $800.00 | -3.75% | 4 | Sep 24, 2025 | |
| VEEV Veeva Systems | Maintains: Outperform | $295 → $325 | $233.11 | +39.42% | 4 | Aug 29, 2025 | |
| NVST Envista Holdings | Maintains: Underperform | $15 → $18 | $20.81 | -13.50% | 2 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $10 | $7.59 | +31.75% | 1 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $65 → $60 | $45.48 | +31.93% | 3 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $21 → $18 | $11.16 | +61.36% | 7 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $70 → $82 | $80.40 | +2.00% | 2 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $126 | $93.70 | +34.47% | 1 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $75 | $74.44 | +0.75% | 5 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $5 | $3.23 | +54.80% | 1 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $18 → $14 | $2.48 | +464.52% | 7 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $142 | $224.90 | -36.86% | 10 | Sep 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $55 | $80.49 | -31.67% | 6 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $82 → $92 | $196.50 | -53.18% | 10 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $565 | $322.59 | +75.14% | 5 | Apr 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $110 → $100 | $79.46 | +25.85% | 1 | Mar 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $17 → $14 | $5.47 | +156.18% | 1 | Feb 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $380 → $400 | $157.05 | +154.70% | 4 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Overweight | $107 | $37.65 | +184.20% | 1 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $22 → $17 | $37.56 | -54.74% | 3 | Apr 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $5 → $12 | $10.62 | +13.05% | 1 | Jun 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $96 | $108.74 | -11.72% | 3 | Nov 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $105 → $120 | $179.63 | -33.20% | 6 | Apr 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $117 → $127 | $484.59 | -73.79% | 1 | Apr 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $327 → $358 | $249.46 | +43.51% | 3 | Dec 6, 2019 |
Phreesia
Dec 10, 2025
Maintains: Outperform
Price Target: $36 → $28
Current: $15.75
Upside: +77.78%
LifeMD
Nov 19, 2025
Maintains: Neutral
Price Target: $8 → $6
Current: $3.58
Upside: +67.60%
GoodRx Holdings
Nov 6, 2025
Maintains: Neutral
Price Target: $5 → $4
Current: $2.69
Upside: +48.70%
Cencora
Nov 6, 2025
Maintains: Outperform
Price Target: $340 → $380
Current: $339.24
Upside: +12.02%
Cardinal Health
Nov 4, 2025
Maintains: Outperform
Price Target: $170 → $210
Current: $198.66
Upside: +5.71%
Waystar Holding
Oct 30, 2025
Maintains: Outperform
Price Target: $48 → $50
Current: $29.90
Upside: +67.22%
Align Technology
Oct 13, 2025
Maintains: Outperform
Price Target: $210 → $170
Current: $161.23
Upside: +5.44%
McKesson
Sep 24, 2025
Maintains: Neutral
Price Target: $750 → $770
Current: $800.00
Upside: -3.75%
Veeva Systems
Aug 29, 2025
Maintains: Outperform
Price Target: $295 → $325
Current: $233.11
Upside: +39.42%
Envista Holdings
Aug 1, 2025
Maintains: Underperform
Price Target: $15 → $18
Current: $20.81
Upside: -13.50%
Jul 25, 2025
Initiates: Neutral
Price Target: $10
Current: $7.59
Upside: +31.75%
May 16, 2025
Maintains: Neutral
Price Target: $65 → $60
Current: $45.48
Upside: +31.93%
Mar 13, 2025
Maintains: Neutral
Price Target: $21 → $18
Current: $11.16
Upside: +61.36%
Mar 3, 2025
Maintains: Neutral
Price Target: $70 → $82
Current: $80.40
Upside: +2.00%
Dec 4, 2024
Initiates: Outperform
Price Target: $126
Current: $93.70
Upside: +34.47%
Dec 4, 2024
Initiates: Neutral
Price Target: $75
Current: $74.44
Upside: +0.75%
Dec 4, 2024
Initiates: Outperform
Price Target: $5
Current: $3.23
Upside: +54.80%
Nov 5, 2024
Maintains: Equal-Weight
Price Target: $18 → $14
Current: $2.48
Upside: +464.52%
Sep 21, 2023
Maintains: Equal-Weight
Price Target: $142
Current: $224.90
Upside: -36.86%
Aug 4, 2023
Maintains: Overweight
Price Target: $55
Current: $80.49
Upside: -31.67%
Aug 2, 2023
Maintains: Overweight
Price Target: $82 → $92
Current: $196.50
Upside: -53.18%
Apr 14, 2023
Maintains: Overweight
Price Target: $565
Current: $322.59
Upside: +75.14%
Mar 30, 2023
Maintains: Overweight
Price Target: $110 → $100
Current: $79.46
Upside: +25.85%
Feb 27, 2023
Maintains: Overweight
Price Target: $17 → $14
Current: $5.47
Upside: +156.18%
Oct 28, 2022
Maintains: Overweight
Price Target: $380 → $400
Current: $157.05
Upside: +154.70%
Jul 28, 2022
Reinstates: Overweight
Price Target: $107
Current: $37.65
Upside: +184.20%
Apr 18, 2022
Downgrades: Equal-Weight
Price Target: $22 → $17
Current: $37.56
Upside: -54.74%
Jun 11, 2021
Upgrades: Overweight
Price Target: $5 → $12
Current: $10.62
Upside: +13.05%
Nov 23, 2020
Upgrades: Overweight
Price Target: $96
Current: $108.74
Upside: -11.72%
Apr 30, 2020
Reiterates: Neutral
Price Target: $105 → $120
Current: $179.63
Upside: -33.20%
Apr 22, 2020
Maintains: Overweight
Price Target: $117 → $127
Current: $484.59
Upside: -73.79%
Dec 6, 2019
Maintains: Overweight
Price Target: $327 → $358
Current: $249.46
Upside: +43.51%